The American Heart Association and the American College of Cardiology have jointly issued a new scientific statement on screening for congenital and genetic heart conditions that can lead to rare sudden death in young persons aged 12 to 25 years.
Last November, the American Heart Association (AHA) and the American College of Cardiology (ACC) recommended statin therapy for approximately 33 million more Americans who don’t have cardiovascular disease (CVD), but have an estimated 10-year CV risk of 7.5% or higher.
Recognizing the rising cost of healthcare and the importance of providing value to patients, resource utilization and value assessments will now be explicitly considered in the development of clinical practice guidelines and performance measures from the American College of Cardiology/American Heart Association.
About 1 of every 3 children in the United States aged between 9 and 11 years has a borderline or deleterious cholesterol profile, according to research presented at the recent annual meeting of the American College of Cardiology (ACC).
Data from a study presented at the American College of Cardiology’s 63rd Annual Scientific Session raise the intriguing question of whether multiparity raises the risk of cardiovascular disease (CVD) in women. The report, by researchers from the University of Texas Southwestern, suggests that plaque in the heart and arterial thickening may be more prevalent in women who give birth four or more times than in those with two to three live births.